This study reports that hair samples can be used to track chronic hormone levels, revealing stress, reproductive, and sodium regulation patterns in wildebeest related to environmental factors.
June 2026 in “World Journal of Urology” Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.
February 2024 in “The Journal of Dermatology” In this study, dutasteride 0.5 mg was found to provide long-term efficacy and safety in treating androgenetic alopecia in Korean men, with 89.9% showing improvement and 93.9% experiencing prevention of disease progression over at least 5 years.
23 citations
,
June 1999 in “Clinical Therapeutics” In this study, finasteride was found to reduce costs associated with benign prostatic hyperplasia compared to watchful waiting and terazosin, especially in men with higher prostate-specific antigen levels.
September 2023 in “Journal of The American Academy of Dermatology” In this study, researchers observed that after 5 years of treatment, 89.9% of Korean men with androgenetic alopecia experienced improvement and 93.9% had prevention of disease progression with dutasteride 0.5mg, though sexual-related symptoms were common early but subsided over time.
September 2023 in “Journal of the American Academy of Dermatology” This study found that the incidence of major adverse cardiovascular events in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis who received Ixekizumab was low and stable over 3 to 5 years across 25 clinical trials.
1 citations
,
May 2022 in “PubMed” This study found that both Billroth-I and Billroth-II reconstruction methods have similar effects on the mid- and long-term quality of life for patients after radical distal gastric cancer surgery.
April 2025 in “The Journal of Urology” In this study, men using finasteride-1 mg long-term for androgenic alopecia were more likely to receive PDE5i prescriptions sooner than non-users, while also having reduced rates of elevated PSA and prostate cancer diagnoses.
May 2026 in “British Journal of Clinical Pharmacology” In this study, researchers observed low variability in hair formoterol concentrations for COPD patients with stable adherence, but inter-patient differences and other factors may limit the effectiveness of hair analysis as a reliable tool for assessing medication adherence.
1 citations
,
October 2022 This study assessed the potential for Ocean Thermal Energy Conversion power in Fiji, finding higher power output and efficiency during summer due to greater temperature differences between surface and deep sea waters.
March 2026 in “Journal for ImmunoTherapy of Cancer” This paper reports insights from an Expert Panel convened by the Society for Immunotherapy of Cancer on managing immune-related adverse events (irAEs) following immune checkpoint inhibitor therapy, highlighting surveillance gaps and the need for a comprehensive irAE registry to improve post-treatment care for cancer survivors.
9 citations
,
December 2008 In this study, untreated men with androgenetic alopecia continued to experience progressive hair loss over a 5-year period, with a significant decline in hair density observed in the placebo group.
2 citations
,
January 2024 In this study, researchers proposed a deep learning approach combining genetic, hormonal, scalp health, and lifestyle data to predict hair loss, employing CNNs for image analysis and RNNs for modeling data over time, although specific results are not reported.
7 citations
,
May 2002 in “Hair transplant forum international” This article reviews long-term data on the efficacy and safety of finasteride over five years but reports no new clinical results.
June 2025 in “British Journal of Dermatology” This study reviewed clinical trials on JAK inhibitors for alopecia areata, finding them effective for short-term hair regrowth with a favorable safety profile, but noted limited data on long-term risks like malignancies or cardiovascular events beyond two years.
10 citations
,
March 2023 in “Journal of Managed Care & Specialty Pharmacy” This study found that patients with alopecia areata had similar total health care costs as those with atopic dermatitis, despite having fewer comorbidities and prescription medications overall.
5 citations
,
June 2023 in “Engineering Technology & Applied Science Research” This study developed a new neural network model (AA-GAN-AB-MTEDeep) to enhance Alopecia Areata classification using synthetic scalp images, achieving an accuracy of 96.94%.
28 citations
,
August 2014 in “Cancer Causes & Control” In this study, there was no evidence that using 5α-reductase inhibitors for either short or long durations increased the risk of male breast cancer.
November 2021 in “Research Square (Research Square)” This study found that numerous long-term effects of SARS-CoV-2 were significantly associated with age and gender, while race, income, and education had limited significance.
1 citations
,
April 2025 in “Scientific Reports” This study developed a culture method to expand and differentiate primary mammary basal cells, identifying key transcription factors like EGR1 and ELF3 that influence Claudin expression and actin organization, offering insights into epithelial cell biology and potential applications in related research fields.
June 2026 in “British Journal of Dermatology” This study found that long-term exposure to particulate matter (PM2.5 and PM10) is associated with an increased risk of developing alopecia areata, with possible involvement of inflammatory pathways, suggesting PM as a modifiable environmental risk factor.
67 citations
,
October 1997 in “Dermatologic Surgery” This study found that the EpiLight Hair Removal System achieved approximately 60% hair removal after 12 weeks following a single treatment, indicating effectiveness and safety for long-term hair reduction.
January 2023 in “MEDS Clinical Medicine” This study found that the morbidity of urinary stones in Wuwei City, China, increased from 1995 to 2016 for both men and women, with distinct geographical clusters identified for monitoring and prevention efforts.
October 2017 in “The Journal of Urology” Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.
May 2026 in “Frontiers in Pharmacology” This study found that long-term use of 5α-reductase inhibitors is associated with improved overall survival in men with renal cell carcinoma, particularly those with low comorbidity not receiving surgery or systemic therapy, suggesting a potential role for androgen modulation in disease management.
4 citations
,
November 2023 in “PLoS ONE” This study observed that online searches in Japan for long-COVID symptoms, such as hair loss, cough, and headache, increased alongside peaks in new COVID-19 cases from 2020 to 2022, highlighting growing public interest in long-COVID.
1 citations
,
October 2023 in “Romanian Journal of Morphology and Embryology” This review analyzed 109 articles to classify skin lesions associated with COVID-19 and their frequency during the disease, but found no conclusive evidence on long-term persistence of specific types due to rarity.
March 2014 in “The Journal of Urology” This study observed that long-term treatment with 5ARIs in men with LUTS/BPH was linked to worsening sexual function, whereas doxazosin alone had minimal negative impact.
151 citations
,
May 2021 in “Frontiers in Medicine” This systematic review observed that a significant number of COVID-19 patients report long-term symptoms, including neurologic complaints and chronic fatigue, highlighting the presence of "post-COVID syndrome.